We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
CCND1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • CCND1
PROTEIN SUMMARY GENE INFORMATION RNA DATA ANTIBODY DATA
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

CCND1
Synonyms BCL1, D11S287E, PRAD1, U21B31
Gene descriptioni

Full gene name according to HGNC.

Cyclin D1
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Cancer-related genes
Disease related genes
FDA approved drug targets
Human disease related genes
Transporters
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 11
Cytoband q13.3
Chromosome location (bp) 69641156 - 69654474
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

2
Ensembl ENSG00000110092 (version 109)
Entrez gene 595
HGNC HGNC:1582
UniProt P24385 (UniProt - Evidence at protein level)
neXtProt NX_P24385
GeneCards CCND1
Antibodypedia CCND1 antibodies


PROTEIN FUNCTION
Protein function (UniProt)i

Useful information about the protein provided by UniProt.

Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition 1, 2, 3, 4, 5, 6. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase 7, 8, 9, 10, 11. Hypophosphorylates RB1 in early G(1) phase 12, 13, 14, 15, 16. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals 17, 18, 19, 20. Also a substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity 21. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex 22. Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner 23, 24.... show less
Molecular function (UniProt)i

Keywords assigned by UniProt to proteins due to their particular molecular function.

Cyclin, Repressor
Biological process (UniProt)i

Keywords assigned by UniProt to proteins because they are involved in a particular biological process.

Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation
Gene summary (Entrez)i

Useful information about the gene from Entrez

The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]... show less
PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The Splice variant identifier links to the Ensembl website protein summary for the selected splice variant. The data in the Swissprot and TrEMBL columns links to corresponding pages in the UniProt database.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide and number of predicted transmembrane region(s) according to in-house majority decision methods based on sets of predictors are also reported.
Splice variant SwissProt TrEMBL Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
CCND1-201
ENSP00000227507
ENST00000227507
P24385
[Direct mapping] G1/S-specific cyclin-D1
Show all
Q6FI00
[Target identity:100%; Query identity:100%] CCND1 protein; Cyclin D1 (PRAD1: parathyroid adenomatosis 1); Cyclin D1, isoform CRA_c; cDNA, FLJ93625, Homo sapiens cyclin D1 (PRAD1: parathyroid adenomatosis 1) (CCND1),mRNA
Show all
Transporters
   Transporter channels and pores
   SPOCTOPUS predicted membrane proteins
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Candidate cancer biomarkers
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Disease related genes
FDA approved drug targets
   Small molecule drugs
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
   Congenital malformations
   Other congenital malformations
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000079 [regulation of cyclin-dependent protein serine/threonine kinase activity]
GO:0000082 [G1/S transition of mitotic cell cycle]
GO:0000122 [negative regulation of transcription by RNA polymerase II]
GO:0000307 [cyclin-dependent protein kinase holoenzyme complex]
GO:0000320 [re-entry into mitotic cell cycle]
GO:0001889 [liver development]
GO:0001934 [positive regulation of protein phosphorylation]
GO:0003714 [transcription corepressor activity]
GO:0004672 [protein kinase activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0005829 [cytosol]
GO:0005923 [bicellular tight junction]
GO:0006468 [protein phosphorylation]
GO:0006974 [cellular response to DNA damage stimulus]
GO:0007049 [cell cycle]
GO:0007595 [lactation]
GO:0008283 [cell population proliferation]
GO:0008284 [positive regulation of cell population proliferation]
GO:0009410 [response to xenobiotic stimulus]
GO:0010033 [response to organic substance]
GO:0010039 [response to iron ion]
GO:0010165 [response to X-ray]
GO:0010243 [response to organonitrogen compound]
GO:0010971 [positive regulation of G2/M transition of mitotic cell cycle]
GO:0014070 [response to organic cyclic compound]
GO:0016020 [membrane]
GO:0016055 [Wnt signaling pathway]
GO:0016301 [kinase activity]
GO:0016538 [cyclin-dependent protein serine/threonine kinase regulator activity]
GO:0017053 [transcription repressor complex]
GO:0019899 [enzyme binding]
GO:0019901 [protein kinase binding]
GO:0030182 [neuron differentiation]
GO:0030857 [negative regulation of epithelial cell differentiation]
GO:0030968 [endoplasmic reticulum unfolded protein response]
GO:0031100 [animal organ regeneration]
GO:0031571 [mitotic G1 DNA damage checkpoint signaling]
GO:0031965 [nuclear membrane]
GO:0032026 [response to magnesium ion]
GO:0032355 [response to estradiol]
GO:0033197 [response to vitamin E]
GO:0033327 [Leydig cell differentiation]
GO:0033598 [mammary gland epithelial cell proliferation]
GO:0033601 [positive regulation of mammary gland epithelial cell proliferation]
GO:0042826 [histone deacetylase binding]
GO:0043524 [negative regulation of neuron apoptotic process]
GO:0043627 [response to estrogen]
GO:0044321 [response to leptin]
GO:0044772 [mitotic cell cycle phase transition]
GO:0044877 [protein-containing complex binding]
GO:0045444 [fat cell differentiation]
GO:0045471 [response to ethanol]
GO:0045737 [positive regulation of cyclin-dependent protein serine/threonine kinase activity]
GO:0048545 [response to steroid hormone]
GO:0051301 [cell division]
GO:0051384 [response to glucocorticoid]
GO:0051412 [response to corticosterone]
GO:0051592 [response to calcium ion]
GO:0051726 [regulation of cell cycle]
GO:0060749 [mammary gland alveolus development]
GO:0070064 [proline-rich region binding]
GO:0070141 [response to UV-A]
GO:0071310 [cellular response to organic substance]
GO:0097128 [cyclin D1-CDK4 complex]
GO:0097421 [liver regeneration]
GO:1900087 [positive regulation of G1/S transition of mitotic cell cycle]
GO:2000045 [regulation of G1/S transition of mitotic cell cycle]
Show all
295 aa
33.7 kDa
No 0
CCND1-203
ENSP00000438482
ENST00000536559
F5H437
[Direct mapping] G1/S-specific cyclin-D1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Cancer-related genes
   Mutated cancer genes
   Mutational cancer driver genes
   COSMIC somatic mutations in cancer genes
   COSMIC Somatic Mutations
   COSMIC Translocations
Human disease related genes
   Cancers
   Head and neck cancers
   Cancers of the digestive system
   Cancers of the breast and female genital organs
   Cancers of haematopoietic and lymphoid tissues
   Congenital malformations
   Other congenital malformations
Protein evidence (Ezkurdia et al 2014)
Show all
67 aa
7.8 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org